LIVE EVENT: The U.S. healthcare law rollout: Where do we stand?
- Global efforts to curb malaria have saved the lives of 3.3 million people since 2000, cutting global death rates from the mosquito-borne disease by 45 percent and by half in children under 5, the World Health Organization said on Wednesday.
- The U.S. Food and Drug Administration said it planned to phase out the use of some antibiotics in animals used for food, to prevent bacteria from becoming resistant to drugs used to treat humans.
- CytRx Corp said its experimental cancer drug improved survival rates in soft tissue sarcoma patients without the disease progressing, compared to chemotherapy alone, sending its shares up 75 percent before the bell.
- Animal health companies Zoetis Inc and Eli Lilly & Co support the U.S. Food and Drug Administration's new voluntary phase-out of antibiotic use in animal production, the agency said during a conference call with reporters.
LONDON - The world needs to fight the spread of dementia in the same way it mobilized against AIDS, a British government minister told a special summit on the disease on Wednesday, saying failure to tackle it would wreck state health budgets.
PARIS - French drugmaker Sanofi said U.S. authorities had decided to carry out a priority review of its experimental pill for patients with Gaucher disease.
- Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10-year agreement to form the largest generic drug sourcing operation in the United States, the world's biggest generic drug market.
NEW YORK (Reuters Health) - Threatening or screaming at teenagers may put them at higher risk for depression and disruptive behaviors such as rule-breaking, a new study suggests.
NEW YORK (Reuters Health) - Young, low-income diabetics may not know they need annual eye exams, a new study suggests.
On Wednesday, December 4 at 10:30 a.m. watch live as experts assess where the U.S. stands in the healthcare law rollout and the resulting health policy implications. Presented by the forum at Harvard School of Public Health in collaboration with Reuters. Live Coverage